Pierre I. Karakiewicz

The impact of time to local tumor destruction on cancer-specific mortality in pT1a renal cell carcinoma

Objective: To evaluate the impact of time to local tumor destruction > 6 months on cancer-specific mortality in patients with pT1a renal cell carcinoma. Methods: Using the Surveillance, Epidemiology, and End Results database (2004–2022), patients with pT1aN0M0 renal cell carcinom...

Survival outcomes with Lutetium-177-PSMA-617 in metastatic castration-resistant prostate cancer patient according to baseline tumor characteristics

Abstract Purpose To investigate cancer-control outcomes in metastatic castration-resistant prostate cancer (mCRPC) patients receiving Lutetium-177 Prostate-Specific Membrane Antigen-617 (Lu-177-PSMA) radioligand therapy according to initial baseline tumor characteristics. Methods...

Age Does Not Independently Predict Biochemical Recurrence in Prostate Cancer Following Radical Prostatectomy: A Comparative Analysis of 4223 pT2N0R0 Patients

ABSTRACT Background Whether younger age independently predicts biochemical recurrence (BCR) after radical prostatectomy (RP) remains controversial because previous studies have included heterogeneous pathological stages and treatment populations. We aimed to determine whether age...